Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

After hours: March 24 at 7:44:11 PM EDT Loading Chart for VRTX ...

Help your organization thrive with an enterprise resource planning (ERP) solution that’s built for growth, optimized for performance, and enhanced with actionable insights delivered through autonomous ...

Streamline every part of SOX. With data, processes, and teams all in one platform, Workiva makes it easier on everyone involved with SOX. Work together in real time from the same data with role-based ...